240
Participants
Start Date
December 1, 2021
Primary Completion Date
March 11, 2022
Study Completion Date
March 11, 2022
Molnupiravir (Esperavir)
Capsules 800 mg, 2 times a day with 12 ±2 hours interval for 5 days
Standard of care
The administration of 'Standard of care' drugs was done according to the regimen recommended in the 'COVID-19 TreatmentGuidelines'(Version 14 of 27.12.2021), or inforce at the time of the study
"Regional Budget Healthcare Institution Ivanovo clinical hospital", Ivanovo
Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov
State Budgetary Healthcare Institution City Clinical Hospital named after S. I. Spasokukotskiy of Moscow Healthcare Department, Moscow
Professorskaya klinika, LLC, Perm
Ryazan State Medical University named after academician I.P. Pavlov of Ministry of Health of the Russian Federation, Ryazan
Avrora MedFort, LLC, Saint Petersburg
OrCli Hospital, LLC, Saint Petersburg
Ogarev Mordova State University of Ministry of Health of the Russian Federation, Saransk
"Regional State Budget Healthcare Institution Clinical hospital No. 1", Smolensk
Smolensk State Medical University of Ministry of Health of the Russian Federation, Smolensk
Uromed, LLC, Smolensk
"State Budgetary Healthcare Institution of Yaroslavl Region Clinical hospital No. 3", Yaroslavl
Promomed, LLC
OTHER